01272nam2 22003133i 450 SUN010440720160111082610.3938-88-598-0914-20.0020151229d2013 |0itac50 baitaIT|||| |||||16: *Impresa e lavoro2.[6][a cura di Marco Aiello, Stefano Ambrosini]2. edTorinoUTET2013VIII, 378 p.24 cm.001SUN00084242001 *Trattato di diritto privatodiretto da Pietro Rescigno16 (2.6)210 TorinoUTET215 volumi24 cm.TorinoSUNL000001346.45Diritto privato. Italia22Ambrosini, StefanoSUNV008474Maiello, MarcoSUNV081422UTETSUNV000072650ITSOL20181109RICAhttp://shop.wki.it/documenti/00143900_ind.pdfSUN0104407UFFICIO DI BIBLIOTECA DEL DIPARTIMENTO DI GIURISPRUDENZA00 CONS XIV.D.122 (16.6) 00 UBG611 UFFICIO DI BIBLIOTECA DEL DIPARTIMENTO DI GIURISPRUDENZAUBG611CONS XIV.D.122 (16.6)caImpresa e lavoro854887UNICAMPANIA02234nam 2200445 450 991058308740332120180818110446.00-12-810492-90-12-810491-0(CKB)3800000000216816(PPN)228046017(MiAaPQ)EBC5050589(EXLCZ)99380000000021681620171018h20182018 uy 0engurcnu||||||||rdacontentrdamediardacarrierMechanical circulatory and respiratory support /editors, Shaun Gregory, John Fraser, Michael StevensLondon, England :Academic Press,2018.©20181 online resource (854 pages)Includes bibliographical references at the end of each chapters and index.Descent into heart and lung failure -- Heart and lung transplantation -- First-generation ventricular assist devices -- Second-generation ventricular assist devices -- Third-generation ventricular assist devices -- Biventricular assist devices -- Total artificial hearts -- Extracorporeal membrane oxygenation -- Pediatric devices -- Hydraulic design -- Motor design and impelier suspension -- Pulsatile vs. continuous flow -- Preclinical evaluation -- Optimizing the patient and timing of the circulatory and extracorporeal respiratory support -- Surgical implantation -- Complications of mechanical circulatory and respiratory support -- Medical management of the supported patient -- Cannula design -- Blood-device interaction -- Physiological control -- Percutaneous and transcutaneous connections -- Wearable systems -- Route to market -- Cost-effectiveness -- The past, present and future.BloodCirculation, ArtificialArtificial respirationBloodCirculation, Artificial.Artificial respiration.617.412Gregory ShaunStevens MichaelFraser John F.MiAaPQMiAaPQMiAaPQBOOK9910583087403321Mechanical circulatory and respiratory support2221812UNINA03806nam 2200649 a 450 991083000940332120230331005431.01-282-34589-397866123458900-470-51352-70-470-51353-5(CKB)1000000000377322(EBL)470674(OCoLC)609849677(SSID)ssj0000312094(PQKBManifestationID)11230274(PQKBTitleCode)TC0000312094(PQKBWorkID)10330941(PQKB)11097480(MiAaPQ)EBC470674(EXLCZ)99100000000037732219870701d1987 uy 0engur|n|---|||||txtccrTumour necrosis factor and related cytotoxins[electronic resource]Chichester ;New York Wiley19871 online resource (254 p.)Ciba Foundation symposium ;131Editors: Gregory Bock (Organizer) and Joan Marsh.Papers presented at the Symposium on Tumour Necrosis Factor and Related Cytotoxins held at the Ciba Foundation, London, 20-22 January 1987."A Wiley-Interscience publication."0-471-91097-X Includes bibliographies and indexes.TUMOUR NECROSIS FACTOR AND RELATED CYTOTOXINS; Contents; Participants; Introduction; Natural production and release of tumour necrosis factor; Possible relationships between in vivo antiturnour activity and toxicity of tumour necrosis factor-a; Human tumour necrosis factors: structure and receptor interactions; Cytocidal activity of tumour necrosis factor: protection by protease inhibitors; Lymphotoxin: cloning, regulation and mechanism of killing; General discussion I; Physiological responses to cachectin; Structure-function relationship of tumour necrosis factor and its mechanism of actionRelationship of tumour necrosis factor and endotoxin to macrophage cytotoxicity, haemorrhagic necrosis and lethal shockAntitumour effects of tumour necrosis factor: cytotoxic or necrotizing activity and its mechanism; Effects of tumour necrosis factor on human tumour xenografts in nude mice; Effects of tumour necrosis factor and related cytokines on vascular endothelial cells; General discussion II; Antiparasitic effects of tumour necrosis factor in vivo and in vitro; Clinical studies with tumour necrosis factor; Summing- up; Index of contributors; Subject indexThe number of factors implicated in the regulation of cell proliferation and differentiation is already considerable and more are continually being identified. This book concentrates on tumor necrosis factor (cachectin) and lymphotoxin, but includes observations of their interactions with other cytokines, especially the interferons and interleukins. TNF can be either cytostatic or cytotoxic to cultured cell lines, and a variety of mechanisms are proposed, ranging from DNA fragmentation to activation of phospholiopases. TNF is also reported to stimulate the growth of normal fibroblasts in vivo.Ciba Foundation symposium ;131.Tumor necrosis factorCongressesCytokinesCongressesTumor necrosis factorCytokines616.99616.992071616.994Bock Gregory322650Marsh Joan91633Symposium on Tumour Necrosis Factor and Related Cytotoxins(1987 :London, England)MiAaPQMiAaPQMiAaPQBOOK9910830009403321Tumour necrosis factor and related cytotoxins4040217UNINA